Research programme: punctal plug therapeutics - Mati TherapeuticsAlternative Names: Difluprednate - punctal plug; Nepafenac - punctal plug; Prostaglandin analogue - punctal plug
Latest Information Update: 07 Oct 2016
At a glance
- Originator Mati Therapeutics
- Class Prostaglandins; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Prostaglandin receptor agonists; Steroid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Glaucoma; Inflammation; Pain
Most Recent Events
- 03 Oct 2016 Early research in Pain, Glaucoma and Inflammation in USA (Ophthalmic)